Michelle Haber

36PUBLICATIONS
321CO-AUTHORS
Molecular targetsCancer geneticsMedical molecular engineering of nucleic acids and proteinsNanotoxicology, health and safetyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jun 13, 2026
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity.

|May 19, 2026
Precision-guided therapy in H3K27-altered diffuse midline glioma.

|Apr 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young.

|Mar 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.

Ashleigh M Fordham, Lauren M Brown, Chelsea Mayoh

|Feb 13, 2026
Integrated Germline and Somatic Molecular Profiling to Detect Cancer Predisposition Has a High Clinical Impact in Poor-Prognosis Pediatric Cancer.

Noemi A Fuentes-Bolanos, Eliza Courtney, Chelsea Mayoh

|Nov 28, 2025
Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma.

Jeremy Z R Han, Monica Phimmachanh, Jordan F Hastings

Pageof 6

Frequent Collaborators

20 joint publications

Chelsea Mayoh

18 joint publications

Murray Norris

13 joint publications

Jamie I Fletcher

9 joint publications

Toby N Trahair